Heart allograft tolerance without development of posttransplant cardiac allograft vasculopathy in cyclophosphamide-induced tolerance.
Shimizu
I
I
Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Tomita
Y
Y
Iwai
T
T
Zhang
Q W
QW
Nakashima
Y
Y
Sueishi
K
K
Yasui
H
H
D000818:Animals; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D051379:Mice; D008806:Mice, Inbred AKR; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism; D016038:Skin Transplantation / Q000276:immunology*; D018183:Transplantation Chimera / Q000276:immunology*; D019172:Transplantation Conditioning; D023001:Transplantation Tolerance / Q000276:immunology*; D014184:Transplantation, Homologous; D014652:Vascular Diseases / Q000517:prevention & control*
D007166:Immunosuppressive Agents; D011948:Receptors, Antigen, T-Cell; D003520:Cyclophosphamide